Last reviewed · How we verify
NCT05924087
Interventional Therapy of Tracheal Stenosis
trial in Tracheal Stenosis Following Tracheostomy in 250 participants. Currently enrolling.
31 December 2025
Quick facts
| Lead sponsor | Asklepios Neurological Clinic Bad Salzhausen |
|---|---|
| Status | Recruiting now |
| Study type | OBSERVATIONAL |
| Enrollment | 250 |
| Start date | 1 June 2023 |
| Primary completion | 31 December 2025 |
| Estimated completion | 31 July 2026 |
| Sites | 1 location across Germany |
Conditions studied
- Tracheal Stenosis Following Tracheostomy — all drugs for Tracheal Stenosis Following Tracheostomy →
Sponsor
Asklepios Neurological Clinic Bad Salzhausen
Who can join
18 and older, any sex, with Tracheal Stenosis Following Tracheostomy. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
After respiratory weaning, decannulation is sought. To do this, the tracheal cannula is first unblocked, so that patients no longer breathe in and out through the cannula, but (at least partially) "passing" the cannula by the natural route. In the presence of tracheal stenosis there is increased breathing effort, possibly restlessness and stridor. This constellation of symptoms suggests the suspicion of tracheal stenosis, so in the next step a tracheoscopy is performed to confirm or exclude tracheal stenosis. In case of symptomatic tracheal stenosis and at least 30-50% stenosis of the trachea (clinical symptoms can be expected from a 30-50% stenosis) then appropriate therapy (here: cryotherapy, other techniques only in exceptional cases) is planned. The goal is to be able to remove the tracheal cannula (long term) after successful therapy, so that patients do not have to be permanently provided with a tracheal cannula. There is no definitive/evidence-based standard therapy for the treatment of tracheal stenosis. Cryotherapy is a gentle therapy that has already been applied and described for the treatment of tracheal stenosis (see above). The examination is performed as part of an analgesic dose, as is routine for a bronchoscopy (in-house SOP). After treatment, a follow-up is planned for about 10 days later.
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
Interventional treatment of post tracheostomy tracheal stenosis in neurological rehabilitation: results of a single-center registry.
Ley L, Klingenberger P, Schlitter T, Hetzel J, et al · · 2026 · PMID 41908175 · DOI 10.3389/fresc.2026.1776925
Verify or expand the search:
- PubMed search for NCT05924087
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other Asklepios Neurological Clinic Bad Salzhausen trials
Trials by the same sponsor.
- NCT05054556 — Galectin and Respiratory Weaning · unknown
- NCT04630236 — Ultrasound Guided Positioning of Central Venous Catheters · NA · completed
- NCT03082339 — Cortisone and QTc-Interval · completed
- NCT05496504 — Pulmonary Hypertension and Arrhythmia · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05924087 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 9 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Asklepios Neurological Clinic Bad Salzhausen
- Last refreshed: 31 July 2024
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05924087.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing